Genprex, Inc. (GNPX) financial statements (2021 and earlier)

Company profile

Business Address 1601 TRINITY STREET, BLDG. B
AUSTIN, TX 78712
State of Incorp. TX
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments27290
Cash and cash equivalents27290
Receivables0000
Other undisclosed current assets3100
Total current assets:31390
Noncurrent Assets
Property, plant and equipment0000
Other noncurrent assets1101
Other undisclosed noncurrent assets   (0)
Total noncurrent assets:1101
TOTAL ASSETS:31491
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:0001
Other undisclosed accounts payable and accrued liabilities0001
Other liabilities0000
Total current liabilities:0101
Noncurrent Liabilities
Total liabilities:0101
Stockholders' equity
Stockholders' equity attributable to parent31390
Common stock0000
Additional paid in capital89433918
Accumulated deficit(58)(40)(30)(17)
Total stockholders' equity:31390
TOTAL LIABILITIES AND EQUITY:31491

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
Gross profit:(0)(0)(0)(0)
Operating expenses(18)(11)(12)(3)
Operating loss:(18)(11)(12)(3)
Nonoperating income (expense)00(0)(0)
Investment income, nonoperating0000
Interest and debt expense  (0)(0)
Loss before gain (loss) on sale of properties:(18)(11)(12)(3)
Other undisclosed net income  0 
Net loss:(18)(11)(12)(3)
Other undisclosed net income attributable to parent   0
Net loss available to common stockholders, diluted:(18)(11)(12)(3)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(18)(11)(12)(3)
Comprehensive loss, net of tax, attributable to parent:(18)(11)(12)(3)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: